These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25529873)

  • 61. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
    Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.
    Schneider G; Probst T; Kirchin MA; Stroeder J; Fries P; Buecker A
    Radiol Med; 2015 Dec; 120(12):1100-11. PubMed ID: 26088468
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
    Iezzi R; Soulez G; Thurnher S; Schneider G; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    Eur J Radiol; 2011 Feb; 77(2):358-68. PubMed ID: 19679417
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI.
    Bryant BJ; Im K; Broome DR
    Clin Radiol; 2009 Jul; 64(7):706-13. PubMed ID: 19520215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multicenter testing of gadobenate dimeglumine in magnetic resonance imaging of focal liver disease.
    Spinazzi A; Pirovano G; Ratcliffe G; Pezzoli C; Rosati G
    Acad Radiol; 1996 Aug; 3 Suppl 2():S415-6. PubMed ID: 8796618
    [No Abstract]   [Full Text] [Related]  

  • 67. Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent.
    Thomeer MG; Gest B; van Beek H; De Vries M; Dwarkasing R; Klompenhouwer AJ; De Man RA; IJzermans JN; Braun L
    J Magn Reson Imaging; 2018 Mar; 47(3):860-861. PubMed ID: 28589549
    [No Abstract]   [Full Text] [Related]  

  • 68. [Optimized detection and characterization of liver metastases : The role of current MRI contrast agents].
    Weinrich JM; Well L; Bannas P
    Radiologe; 2017 May; 57(5):373-381. PubMed ID: 28204853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of contrast-enhanced fluid-attenuated inversion recovery sequence to detect brain lesions in dogs and cats.
    Merhof K; Lang J; Dürr S; Stahl C; Gorgas D
    J Vet Intern Med; 2014; 28(4):1263-7. PubMed ID: 24962604
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diffusion-Weighted Imaging: An Exciting and Problem-Solving Tool in Patients with Hepatic Metastases.
    Gupta S; Choh NA; Bhatt MG; Wani RA; Rasool Z; Rasool SR
    Indian J Radiol Imaging; 2021 Jan; 31(1):86-90. PubMed ID: 34316115
    [No Abstract]   [Full Text] [Related]  

  • 71. Cardiac magnetic resonance imaging in normal dogs and two dogs with heart base tumor.
    Mai W; Weisse C; Sleeper MM
    Vet Radiol Ultrasound; 2010; 51(4):428-35. PubMed ID: 20806875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of hepatic neoplasia on life expectancy in dogs.
    Vilkovyskiy IF; Vatnikov YA; Kulikov EV; Sotnikova ED; Yagnikov SA; Seleznev SB; Krotova EA; Byakhova VM; Grishin VN; Avdotin VP
    Vet World; 2020 Mar; 13(3):413-418. PubMed ID: 32367943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.
    Hwang HS; Kim SH; Jeon TY; Choi D; Lee WJ; Lim HK
    Korean J Radiol; 2009; 10(3):294-302. PubMed ID: 19412518
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Feasibility for detecting liver metastases in dogs using gadobenate dimeglumine-enhanced magnetic resonance imaging.
    Louvet A; Duconseille AC
    Vet Radiol Ultrasound; 2015; 56(3):286-95. PubMed ID: 25529873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
    Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM
    J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine.
    Brismar TB; Kartalis N; Kylander C; Albiin N
    Eur Radiol; 2012 Mar; 22(3):633-41. PubMed ID: 21953376
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.